Insulin-dependent diabetes mellitus and prenatal screening results: Current experience from a regional screening programme

Prenatal Diagnosis

Volumn 16, Issue 11, 1996, Pages 1039-1042

  Crossley, Jennifer A ^a   Berry, Esther ^a   Aitken, David A ^a   Connor, J Michael ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Alpha fetoprotein; Human chorionic gonadotrophin; Insulin dependent diabetes mellitus; Prenatal screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADOLESCENT; ADULT; ARTICLE; DOWN SYNDROME; FEMALE; FETUS; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL;

EID: 0029848642     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0223(199611)16:11<1039::aid-pd985>3.0.co;2-#     Document Type: Article

References (12)

1. Baumgarten, A., Robinson, J. (1988). Prospective study of an inverse relationship between maternal glycosylated haemoglobin and serum α-fetoprotein concentrations in pregnant women with diabetes, Am. J. Obstet. Gynecol., 159, 78-81.
2. Canick, J.A., Panizza, D.S., Palomaki, G.E. (1990). Prenatal screening for Down's syndrome using AFP, uE3 and hCG: effect of maternal race, insulin-dependent diabetes and twin pregnancy, Am. J. Hum. Genet., 47, A270.
3. Crossley, J.A., Aitken, D.A. Connor, J.M. (1991). Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein and age, Prenat. Diagn., 11, 83-101.
4. Crossley, J.A., Aitken, D.A., Berry, E., Connor, J.M. (1994). Impact of a regional screening programme using serum α-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland, J. Med. Screening, 1, 180-183.
5. Cuckle, H.S., Wald, N.J., Thomson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and alpha-fetoprotein level, Br. J. Obstet. Gynaecol, 94, 387-402.
6. Henriques, C.U., Damm, P., Tabor, A., Pedersen, J.F., Molsted-Pedersen, L. (1993). Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy, Obstet. Gynecol., 82, 960-974.
7. Martin, A.O., Dempsey, L.M., Minogue, J., Liu, K., Keller, J., Tamura, R., Freinkel, N. (1990). Maternal serum α-fetoprotein levels in pregnancies complicated by diabetes: implications for screening programmes, Am. J. Obstet. Gynecol., 163, 1209-1216.
8. Milunsky, A., Alpert, E., Kitzmiller, J.L., Younger, M.D., Neff, R.K. (1982). The importance of serum alpha-fetoprotein screening in diabetic women. Am. J. Obstet. Gynecol., 142, 1030-1032.
9. Palomaki, G.E., Knight, G.J., Haddow, J.E. (1994). Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome, Prenat. Diagn., 14, 65-68.
10. Reese, E.A., Davis, N., Mahoney, M.J., Baumgarten, A. (1987). Maternal serum alpha-fetoprotein in diabetic pregnancy: correlation with blood glucose control, Lancet, ii, 275.
11. Wald, N.J., Cuckle, H., Boreham, J., Stirrat, G.M., Turnbull, A.C. (1979). Maternal serum alpha-fetoprotein and diabetes mellitus, Br. J.Obstet. Gynaecol., 86, 357-362.
12. Wald, N.J., Cuckle, H.S., Densem, J.W., Stone, R.B. (1992). Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome, Br. J. Obstet. Gynaecol., 99, 51-53.